
AION Healthspan Launches First-in-Human Clinical Trial for REJUVXL™ Cell Therapy in Chronic Kidney Disease
AION Healthspan announces enrollment for its first-in-human Phase I/II clinical trial in Diabetic Nephropathy and other forms of Chronic Kidney Disease. MIAMI, FL, UNITED STATES, March 2, 2025 /EINPresswire.com/ -- AION Healthspan, Inc., a …